Levinson Axelrod Investigates Xarelto Injuries After New Reports Link the Blood Thinner to Dangerous Side Effects

A new study and several lawsuits link Xarelto with uncontrollable bleeding injuries and increased risks of hemorrhage, stroke, pulmonary embolism, and death. Attorneys for Levinson Axelrod are investigating claims that the drug may be too dangerous for patients.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Attorneys at Levinson Axelrod are taking note of the growing number of complaints against Xarelto, and are investigating potential lawsuits on behalf of those who were injured by the drug.

Edison, NJ (PRWEB) August 07, 2014

The law firm of Levinson Axelrod is examining new reports that the blood thinner Xarelto, manufactured in Germany by Janssen Pharmaceuticals, Inc., and Bayer AG, may be linked to severe adverse side effects, such as uncontrollable bleeding and an increased risk of blood clots.

Reuters reported on June 14, 2014, that several lawsuits had been filed in the United States against the makers of Xarelto, German pharmaceutical manufacturers Janssen Pharmaceuticals, Inc., and Bayer AG.

One of these lawsuits, Packard v. Janssen Research & Development, LLC, et al. (Case No. 9:14cv 80831, U.S. District Court for the Southern District of Florida) accuses the pharmaceutical companies of failing to warn consumers of the potential side effects of the medication and intentionally misleading patients about Xarelto’s safety.

A May 7, 2014 report by the Institute for Safe Medication Practices (ISMP) charted the negative side effects of Xarelto conveyed to the FDA in 2013. The report found that Xarelto side effects are increasing steadily as the drug becomes more popular.

According to the ISMP, there were 989,000 prescriptions written for Xarelto in 2013. In the first three months of that year, there were 680 side effects reported, which included hemorrhages, strokes, pulmonary embolisms, and deaths. While uncontrolled bleeding complications were most common (due to the nature of anticoagulants), the same report also noted that lower, 10mg doses of Xarelto were linked to an increased risk of blood clots.

Attorneys at Levinson Axelrod are taking note of the growing number of complaints against Xarelto, and are investigating potential lawsuits on behalf of those who were injured by the drug. Levinson Axelrod is pleased to offer free consultations for anyone who took Xarelto and may have suffered adverse effects from the medication.

About Levinson Axelrod, P.A.

The attorneys at Levinson Axelrod have been serving the people of New Jersey for 75 years. The firm maintains seven offices located throughout New Jersey for the convenience of its clients. Levinson Axelrod is experienced in many types of personal injury law, including pharmaceutical litigation, nursing home abuse, medical malpractice, wrongful death litigation, auto accidents, and products liability lawsuits.

For a free and confidential case consultation, contact Levinson Axelrod by visiting http://www.njlawyers.com or call 1-800-346-5529.

Levinson Axelrod
2 Lincoln Highway
Edison, NJ 08818-2905
(800) 346-5529
(732) 494-2727